Production (Stage)
Lexeo Therapeutics, Inc.
LXEO
$4.11
$0.235.93%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 99.83M | 121.52M | 157.02M | 174.98M | 195.06M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.44M | 4.60M | 2.44M | 2.17M | 3.03M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 105.27M | 126.12M | 159.46M | 177.15M | 198.09M |
|
|
|||||
| Total Current Assets | 105.27M | 126.12M | 159.46M | 177.15M | 198.09M |
| Net Property, Plant & Equipment | 10.13M | 10.56M | 11.16M | 11.61M | 11.86M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.25M | 3.25M | 3.25M | 3.25M | 3.25M |
| Total Assets | 125.69M | 146.94M | 173.87M | 192.01M | 213.21M |
|
|
|||||
| Total Accounts Payable | 11.98M | 6.42M | 8.44M | 5.77M | 4.30M |
| Total Accrued Expenses | 15.53M | 12.82M | 15.14M | 10.22M | 14.40M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.65M | 2.67M | 2.68M | 2.67M | 2.61M |
| Total Finance Division Other Current Liabilities | 669.00K | 939.00K | 554.00K | 220.00K | 326.00K |
| Total Other Current Liabilities | 669.00K | 939.00K | 554.00K | 220.00K | 326.00K |
| Total Current Liabilities | 30.82M | 22.85M | 26.82M | 18.88M | 21.63M |
|
|
|||||
| Total Current Liabilities | 30.82M | 22.85M | 26.82M | 18.88M | 21.63M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.75M | 7.25M | 7.72M | 8.18M | 8.63M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 37.58M | 30.10M | 34.54M | 27.06M | 30.26M |
|
|
|||||
| Common Stock & APIC | 401.02M | 397.14M | 393.59M | 389.72M | 386.47M |
| Retained Earnings | -312.83M | -280.17M | -254.25M | -224.76M | -203.52M |
| Treasury Stock & Other | -71.00K | -120.00K | -13.00K | -13.00K | -- |
| Total Common Equity | 88.12M | 116.84M | 139.33M | 164.95M | 182.95M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 88.12M | 116.84M | 139.33M | 164.95M | 182.95M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 88.12M | 116.84M | 139.33M | 164.95M | 182.95M |
|
|
|||||